Tonix Pharmaceuticals releases more data from second positive Phase 3 clinical trial of TNX-102 SL
Tonix Pharmaceuticals announces key topline data from 2nd Phase 3 Clinical Trial of TNX-102 SLПодробнее
Tonix Pharmaceuticals Presents Promising Data on Fibromyalgia Treatment at Global ConferenceПодробнее
Tonix Pharmaceuticals CEO Discusses New Drug Application for Fibromyalgia TreatmentПодробнее
Tonix Pharmaceuticals fibromyalgia study published in American College of RheumatologyПодробнее
Tonix Pharmaceuticals finish Phase 3 trial of TNX-102 SL for management of FibromyalgiaПодробнее
Tonix Pharmaceuticals releases positive results from Proof-Of-Concept Study on TNX-102 SLПодробнее
Tonix Pharmaceuticals (TNXP) releases TNX-102 SL for the Treatment of PTSDПодробнее
Tonix Pharmaceuticals drug TNX-102 SL gets FDA ok for US Department of Defense funded trialПодробнее
Tonix Pharmaceuticals updates on fibromyalgia study enrollment, FY 2020 resultsПодробнее
Tonix Pharmaceuticals (TNXP) NobleCon18 Presentation ReplayПодробнее
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)Подробнее
Tonix Pharmaceuticals gets FDA Fast Track designation for fibromyalgia therapyПодробнее
Could TNXP Reach 3-4$ soon?! - Reddit recommendsПодробнее
Overview of the Phase III ENHANCE trial schemaПодробнее
$TNXP Stock - Upcoming milestones + Reverse split risk! - Due Diligence & Technical analysisПодробнее
$TNXP TONIX Pharmaceuticals FDA APPROVAL FOR INCURABLE DISEASEПодробнее
Tonix Pharmaceuticals (TNXP Stock) is Still Ready to Take Off and With Other Great Ideas as Well!Подробнее